New drug combo aims to tackle tough leukemia without chemo
Disease control
Not yet recruiting
This study tests whether combining two targeted drugs, inotuzumab and blinatumomab, is safe and effective for adults newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL) who cannot tolerate standard chemotherapy. About 26 participants will receive the drugs together. …
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 08, 2026 12:02 UTC